This research project is designed to see if treatment with the Replexa+ shortwave diathermy device daily for 3 months will improve blood flow in the lower legs and feet of patients diagnosed with peripheral artery disease and peripheral neuropathy.
Diagnosis of peripheral artery disease (PAD).
ankle brachial index (ABI) greater than or equal to 0.6 mmHg, as measured no more than 6 months prior to screening
resting toe brachial index (TBI) greater than or equal to 0.4, as measured no more than 6 months prior to screening
Diagnosis of peripheral neuropathy, as evidenced by review of medical records.
Impaired skin integrity in the location(s) to be treated.
Current wounds or ulcerations.
Diagnosis of active bleeding tendencies, hemorrhage, or thrombosis.
2+ pitting edema in either lower extremity.
Indiana University
Lead sponsor
ProMedTek, Inc.
Collaborator